WSTAM
LH icon

Wilbanks Smith & Thomas Asset Management’s Labcorp LH Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$11.5M Buy
52,537
+1,574
+3% +$347K 0.32% 78
2023
Q4 		$11.6M Buy
50,963
+5,548
+12% +$1.17M 0.35% 79
2023
Q3 		$9.13M Sell
45,415
-6,828
-13% -$1.44M 0.32% 79
2023
Q2 		$10.8M Sell
52,243
-4,410
-8% -$855K 0.36% 68
2023
Q1 		$11.2M Sell
56,653
-754
-1% -$155K 0.39% 68
2022
Q4 		$11.6M Buy
57,407
+735
+1% +$144K 0.44% 60
2022
Q3 		$9.97M Buy
56,672
+1,468
+3% +$301K 0.43% 58
2022
Q2 		$11.1M Sell
55,204
-220
-0.4% -$46.9K 0.47% 51
2022
Q1 		$11.7M Buy
55,424
+1,574
+3% +$370K 0.47% 50
2021
Q4 		$14.5M Buy
53,850
+1,288
+2% +$319K 0.51% 42
2021
Q3 		$12.7M Buy
52,562
+252
+0.5% +$63.5K 0.5% 41
2021
Q2 		$12.4M Buy
52,310
+1,628
+3% +$371K 0.49% 43
2021
Q1 		$11.1M Buy
50,682
+3,397
+7% +$682K 0.48% 41
2020
Q4 		$8.27M Buy
47,285
+2,852
+6% +$493K 0.39% 65
2020
Q3 		$7.19M Buy
44,433
+3,056
+7% +$484K 0.39% 63
2020
Q2 		$5.91M Buy
41,377
+3,964
+11% +$548K 0.36% 65
2020
Q1 		$4.06M Buy
37,413
+5,873
+19% +$846K 0.3% 69
2019
Q4 		$4.58M Buy
31,540
+2,776
+10% +$401K 0.27% 80
2019
Q3 		$4.15M Buy
28,764
+126
+0.4% +$18.4K 0.26% 83
2019
Q2 		$4.25M Buy
28,638
+1,345
+5% +$188K 0.27% 86
2019
Q1 		$3.59M Buy
27,293
+25,009
+1,095% +$3.08M 0.23% 93
2018
Q4 		$248K Sell
2,284
-11
-0.5% -$1.47K 0.02% 299
2018
Q3 		$342K Buy
2,295
+225
+11% +$34.2K 0.02% 287
2018
Q2 		$319K Sell
2,070
-104
-5% -$15.7K 0.03% 251
2018
Q1 		$302K Sell
2,174
-532
-20% -$78.1K 0.02% 260
2017
Q4 		$371K Sell
2,706
-681
-20% -$90K 0.03% 236
2017
Q3 		$439K Hold
3,387
– – 0.04% 206
2017
Q2 		$449K Hold
3,387
– – 0.04% 194
2017
Q1 		$417K Hold
3,387
– – 0.04% 191
2016
Q4 		$374K Buy
+3,387
New +$376K 0.03% 192
2015
Q2 		– Sell
-2,328
Closed -$252K – 316
2015
Q1 		$252K Hold
2,328
– – 0.02% 261
2014
Q4 		$216K Sell
2,328
-26
-1% -$2.3K 0.02% 280
2014
Q3 		$206K Sell
2,354
-81
-3% -$7.32K 0.02% 265
2014
Q2 		$214K Sell
2,435
-50
-2% -$4.33K 0.02% 266
2014
Q1 		$210K Buy
+2,485
New +$198K 0.02% 260
2013
Q4 		– Sell
-2,718
Closed -$231K – 291
2013
Q3 		$231K Sell
2,718
-425
-14% -$35.8K 0.03% 241
2013
Q2 		$270K Buy
+3,143
New +$261K 0.04% 212

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's LH Position: Q1 2024 in Review

Wilbanks Smith & Thomas Asset Management increased its Labcorp (LH) stake by 3.1% in Q1 2024, buying an estimated $347K and bringing the position to 52,537 shares worth $11.5M. The position accounts for 0.32% of the portfolio, ranked #78.

Wilbanks Smith & Thomas Asset Management first reported a position in LH in Q2 2013 and has held it in 37 quarters since. The position peaked at $14.5M in Q4 2021. 928 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Wilbanks Smith & Thomas Asset Management held 52,537 shares of Labcorp worth $11.5M as of Q1 2024.
  • Wilbanks Smith & Thomas Asset Management bought 1,574 Labcorp shares in Q1 2024, an estimated $347K.
  • Labcorp made up 0.32% of Wilbanks Smith & Thomas Asset Management's portfolio in Q1 2024, its #78 holding.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Labcorp in Q2 2013 and has held it in 37 quarters since.
  • Wilbanks Smith & Thomas Asset Management's Labcorp position peaked at $14.5M in Q4 2021.
  • 928 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2024, filed 7 May 2024.